In this trial, TGFB1 and IL-8 mRNA positively correlated with the immunologic responses to glioma antigens in the EVs isolated from the post-vaccine group, suggesting the potential of mRNAs carried by EVs to assess the response of vaccination therapy in glioma patients (Muller et al., 2015). Here, CXCL8 is linked to central nervous system cancer.